Abstract 18190: Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial — Andreas Goette (2017) | RDL Network
Abstract 18190: Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial
Article 2017 en
Authors
AG
Andreas Goette
JG
Joris R. de Groot
JH
Jean‐Yves Le Heuzey
Abstract
1 min read
Background: In the ENSURE-AF study (NCT 02072434), the oral factor Xa inhibitor edoxaban showed a similar efficacy and safety profile vs enoxaparin-warfarin (enox-warf) in patients undergoing elect...
Ariel A. Cohen, Hein Heidbüchel, Jean‐Yves Le Heuzey, Raffaele De Caterina, José Luís Merino, James Jin, Michael Melino, Shannon M. Winters, Andreas Goette, Professor Gregory Lip
Hee Tae Yu, Pil‐Sung Yang, Tae‐Hoon Kim, Eunsun Jang, Daehoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Professor Gregory Lip, Boyoung Joung
Discussion(0)
No comments yet. Be the first to comment.